Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,774,600
+$512,250 QoQ
Shares Held
15,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.26%
of 13F equity value
Holder Rank
#1,497
of 4,167 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sivik Global Healthcare LLC holds $30,182,950 across 7 Drug Manufacturers - General names. ABBV ranks #5 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,000 | $5,997,150 | |
| 2 | MRK |
Merck & Co., Inc.
|
40,000 | $5,140,000 | |
| 3 | JNJ |
Johnson & Johnson
|
20,000 | $5,079,400 | |
| 4 | AZN |
Astrazeneca PLC
|
20,000 | $3,792,400 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
15,000 | $3,774,600 | |
| 6 | BIIB |
Biogen Inc.
|
15,000 | $3,240,900 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
25,000 | $3,158,500 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,774,600 | 15,000 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $3,262,350 | 15,000 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $4,569,800 | 20,000 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $4,630,800 | 20,000 | Shares | Sole | 2025-10-23 | |
| 2024-12-31 | $4,442,500 | 25,000 | Shares | Sole | 2025-01-23 | |
| 2023-03-31 | $6,374,800 | 40,000 | Shares | Sole | 2023-05-08 | |
| 2022-03-31 | $3,242,200 | 20,000 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $5,416,000 | 40,000 | Shares | Sole | 2022-02-08 | |
| 2021-06-30 | $2,252,800 | 20,000 | Shares | Sole | 2021-08-10 | |
| 2020-06-30 | $1,276,340 | 13,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $761,900 | 10,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||